Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Jaks, Stats and the immune system

T Decker1, A Meinke

  • 1Vienna Biocenter, Institute of Microbiology and Genetics, Austria. decker@gem.univie.ac.at

Immunobiology
|January 27, 1998
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

First-line ET plus palbociclib versus standard mono-chemotherapy in high-risk HR-positive/HER2-negative metastatic breast cancer and indication for chemotherapy: primary results from the randomized phase IV PADMA study.

ESMO open·2026
Same author

Unmet need for patients with metastatic triple-negative breast cancer initiating first-line treatment: data from the prospective German tumor registry OPAL.

ESMO real world data and digital oncology·2026
Same author

Final results of the INFINITY precision oncology registry: non-standard targeted treatments in patients with advanced cancers in routine care.

ESMO real world data and digital oncology·2026
Same author

Risk of disease progression in first-line metastatic colorectal cancer therapy to guide disease reassessments-analysis of 11 trials by AIO and GONO.

Annals of oncology : official journal of the European Society for Medical Oncology·2025
Same author

Conditional progression-free survival in patients with metastatic hormone receptor-positive, human epidermal growth factor receptor 2-negative breast cancer treated with first-line ribociclib and endocrine therapy: real-world data from the RIBANNA study.

ESMO open·2025
Same author

Impact of primary tumor sidedness and sex on prognosis and anti-epidermal growth factor receptor antibody efficacy in BRAF-mutant metastatic colorectal cancer: a pooled analysis of AIO studies FIRE-1, CIOX, FIRE-3, XELAVIRI, and VOLFI.

ESMO open·2024
Same journal

WD-3 improves anti-PD-L1 therapy by remodeling the tumor immune microenvironment through gut microbiota.

Immunobiology·2026
Same journal

Interleukin 27 (IL-27) in gastrointestinal cancers: from dual roles in tumor immunity to immunotherapeutic opportunities.

Immunobiology·2026
Same journal

ST2-mediated ERK/JNK/P38/NF-κB signaling: a target of Biminkang mixture in minimal persistent inflammation of allergic rhinitis.

Immunobiology·2026
Same journal

Chronic stress promotes colorectal cancer progression by inducing M2 macrophage polarization and activating the CCL2-CCR2 axis.

Immunobiology·2026
Same journal

Spatial-cellular resolution analysis of ferroptosis-associated immune microenvironment heterogeneity in osteoarthritic cartilage.

Immunobiology·2026
Same journal

Exploring therapeutic targets for neuroinflammation in sepsis-associated encephalopathy: a combined network pharmacology and bioinformatics approach.

Immunobiology·2026
See all related articles

Cellular responses to immune signals rely on gene expression changes, often mediated by the Janus kinase-signal transducer and activator of transcription (Jak-Stat) pathway. This pathway is crucial for cytokine receptor signaling and immune cell function.

Area of Science:

  • Immunology
  • Molecular Biology
  • Cell Biology

Background:

  • Adaptive cellular responses to immunological stimuli require changes in gene expression.
  • Cell surface receptors initiate regulatory signals, often by modulating transcription factors.
  • The Janus kinase-signal transducer and activator of transcription (Jak-Stat) signaling pathway is central to cytokine receptor function.

Purpose of the Study:

  • To provide an overview of the Jak-Stat signaling pathway.
  • To discuss recent advancements and outstanding questions regarding Jak and Stat molecules.
  • To explore the biological implications of Jak-Stat pathway activity.

Main Methods:

  • Review of existing literature on the Jak-Stat pathway.
  • Analysis of molecular mechanisms of Jak and Stat regulation.

Related Experiment Videos

  • Discussion of biological outcomes associated with Jak-Stat signaling.

    • Main Results:

    • The Jak-Stat pathway involves Janus kinases (Jaks) and Signal Transducers and Activators of Transcription (Stats).
    • Jaks are receptor-associated tyrosine kinases; Stats are transcription factors that translocate to the nucleus.
    • This pathway is essential for transmitting signals from cytokine receptors to regulate gene expression.

    Conclusions:

    • The Jak-Stat pathway is a fundamental mechanism for immune cell signaling and gene regulation.
    • Further research is needed to fully understand the complexities of Jak and Stat regulation and their biological roles.
    • Understanding this pathway is critical for advancing molecular immunology.